Introduction

Novocrine Primosim E100 is presented in a 10-milliliter multidose vial, labeled to contain 100 milligrams of methenolone enanthate per milliliter. As part of its commitment to harm reduction, AnabolicLab procured samples of this product from an internet-based reseller to independently assess its label claims and analyze its quality. The samples were purchased between June 1, 2015, and June 30, 2015, and submitted to SIMEC AG, an internationally accredited analytical laboratory, for comprehensive testing.

The analysis, funded by AnabolicLab, included HPLC-UV quantitative dosage testing. The results indicated a significant discrepancy between the labeled and actual methenolone enanthate content, highlighting concerns about product authenticity and reliability. These findings are published exclusively for educational and harm reduction purposes, helping consumers make informed decisions.

Testing Results and Authentication

The samples were received by SIMEC AG on July 10, 2015, and the report was finalized on July 16, 2015.

Product Overview

• Manufacturer: Novocrine
• Product Name: Primosim E100
• Active Ingredient: Methenolone Enanthate
• Batch Number: Not provided
• Expiration Date: October 2017
• Delivery Method: Injectable (10-milliliter multidose vial)
• Specification: 100 mg/ml methenolone enanthate

Sample Acquisition and Testing

• Date Purchased: Between June 1, 2015, and June 30, 2015
• Source: Internet-based reseller
• Product Submitted By: AnabolicLab
• Analysis Paid For By: AnabolicLab
• Analysis Performed By: SIMEC AG
• Date Received by Lab: July 10, 2015
• Date Report Completed: July 16, 2015

Testing Results

Quantitative Dosage Testing (HPLC-UV):

• Claimed Dosage: 100 mg/ml methenolone enanthate
• Measured Dosage: 4 mg/ml methenolone enanthate
• Accuracy: 4% (significantly below the label claim)
• Variance: -96% (measured dosage was 96% below the label claim)

Summary

The analysis of Novocrine Primosim E100 revealed a dramatic shortfall in the measured content of methenolone enanthate, with only 4 mg/ml detected compared to the label claim of 100 mg/ml, representing a 96% variance. This discrepancy raises significant concerns about the authenticity and quality of this product. Consumers are urged to exercise caution when purchasing such products from unauthorized sources. Independent testing, as conducted here, underscores the importance of transparency and accountability in the anabolic steroid market.

Correction and Additional Notes

On February 4, 2016, a correction was issued regarding the original article’s misrepresentation of the product’s source. Novocrine confirmed that it does not authorize any reseller to sell its products on online platforms and does not have an official European-based distributor. This information further highlights the risks associated with purchasing products from unauthorized sources.

Commitment to Harm Reduction

AnabolicLab is committed to reducing harm by conducting independent testing and providing transparent results. These analyses empower consumers with reliable information, promote product safety, and encourage accountability within the anabolic steroid market.

Disclaimer
The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the Novocrine Primosim E100 lab test results on the AnabolicLab Forum.

(The following images are photographs of the actual product that was submitted for testing.)

Novocrine Primosim E100 Dosage Quantification Lab Results [PDF]
How many milligrams of methenolone enanthate (aka Primobolan Depot) does each tablet of Novocrine Primosim E100 contain? HPLC-UV (July 16, 2015) …

Size	130.20 KB
Downloaded	1065 times
Last Updated	February 6, 2016
Download

---